
Keywords: API; active pharmaceutical ingredient; AUC; area under the curve; BSA; bovine serum albumin; Cmax; peak concentration; COPD; chronic obstructive pulmonary disease; DPI; dry powder inhaler; DPPC; dipalmitoylphosphatidylcholine; ED; emitted dose; EMA; Europ